Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27654219)
Watch
English
Fragment-based identification of Hsp90 inhibitors
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Fragment-based identification of Hsp90 inhibitors
(English)
0 references
author
Saverio Minucci
series ordinal
18
object named as
Saverio Minucci
0 references
author name string
John J Barker
series ordinal
1
0 references
Oliver Barker
series ordinal
2
0 references
Roberto Boggio
series ordinal
3
0 references
Viddhata Chauhan
series ordinal
4
0 references
Robert K Y Cheng
series ordinal
5
0 references
Vincent Corden
series ordinal
6
0 references
Stephen M Courtney
series ordinal
7
0 references
Neil Edwards
series ordinal
8
0 references
Virginie M Falque
series ordinal
9
0 references
Fulvia Fusar
series ordinal
10
0 references
Mihaly Gardiner
series ordinal
11
0 references
Estelle M N Hamelin
series ordinal
12
0 references
Thomas Hesterkamp
series ordinal
13
0 references
Osamu Ichihara
series ordinal
14
0 references
Richard S Jones
series ordinal
15
0 references
Owen Mather
series ordinal
16
0 references
Ciro Mercurio
series ordinal
17
0 references
Christian A G N Montalbetti
series ordinal
19
0 references
Annett Müller
series ordinal
20
0 references
Deepti Patel
series ordinal
21
0 references
Banu G Phillips
series ordinal
22
0 references
Mario Varasi
series ordinal
23
0 references
Mark Whittaker
series ordinal
24
0 references
Dirk Winkler
series ordinal
25
0 references
Christopher J Yarnold
series ordinal
26
0 references
publication date
June 2009
0 references
published in
ChemMedChem
0 references
volume
4
0 references
issue
6
0 references
page(s)
963-6
0 references
cites work
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure, function, and mechanism of the Hsp90 molecular chaperone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development and application of Hsp90 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hsp90 as a target for drug development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Structure-based discovery of a new class of Hsp90 inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fragment-based activity space: smaller is better
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fragment based drug discovery using fluorescence correlation: spectroscopy techniques: challenges and solutions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCMDC.200900011
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CMDC.200900011
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3863387
OpenCitations bibliographic resource ID
3863387
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3863387
PubMed publication ID
19301319
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
3863387
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
